PneumoWave (AI) — Funding, Investors & Signals 2026

PneumoWave

AI-Driven Wearable Motion Sensing for Life Threatening Conditions

Founded 2018

United Kingdom 21 employees Series A Total: $10.60M AI, Health Care +4

PneumoWave is a UK-based startup founded in 2018 that is making waves in the healthcare and AI industries. The company's slogan, "AI-Driven Wearable Motion Sensing for Life-Threatening Conditions," encapsulates its mission. PneumoWave leverages real-time physiological and behavioral data from its wearable biosensor to screen, monitor, and alert patients at risk of life-threatening conditions. With a virtual-first approach, the company aims to revolutionize the response and management of respiratory conditions by harnessing the power of AI. In January 2023, PneumoWave secured a significant £7.50M Series A investment. Notable investors participating in this funding round included Scottish Enterprise, Scottish National Investment Bank, Equity Gap, Intuitive Investments Group, London & Scottish Investment Partners, Alba Equity, and Mark Bamforth. This level of support from a diverse group of investors speaks to the promising potential of PneumoWave's innovative approach to healthcare technology. PneumoWave's focus on AI, health care, medical devices, autonomous and sensor tech, and machine learning places it at the intersection of cutting-edge technology and life-saving healthcare solutions. With its headquarters in the United Kingdom, PneumoWave is well-positioned to drive forward the advancement of wearable motion sensing for life-threatening conditions and contribute to the evolution of virtual-first healthcare practices.

Funding Stage	Amount	Investors	Lead Investors	Date
Series A	£7.50M	7	Scottish Enterprise, Scottish National Investment Bank +5	12 Jan 2023
Seed Round	$3.10M	3	Equity Gap, Intuitive Investments Group +1	16 Apr 2021

Funding Stage

Amount

Investors

Lead Investors

Date

Series A

£7.50M

Scottish Enterprise, Scottish National Investment Bank +5

12 Jan 2023

Seed Round

$3.10M

Equity Gap, Intuitive Investments Group +1

16 Apr 2021

FAQ About PneumoWave

AI-Driven Wearable Motion Sensing for Life Threatening Conditions

PneumoWave was founded in 2018.

PneumoWave is headquartered in United Kingdom.

PneumoWave operates in AI, Health Care, Health and Wellness, Medical Devices, Autonomous and Sensor Tech and Machine Learning. Its work centres on Wearable Technology, AI-driven Healthcare, Virtual Care and Remote Monitoring. Its customers include Medical professionals, Hospitals and Healthcare institutions.

PneumoWave has approximately 21 employees.

PneumoWave has completed 2 funding rounds, raising a total of $10.60M. The latest funding stage is Series A.

PneumoWave offers: Wearable motion sensing technology, Real-time respiratory monitoring, Data collection and analysis.

Top alternatives and competitors to PneumoWave include ZOLL-Itamar Remote Patient Monitoring Business Unit (Formerly Spry Health), Sonara Health, Mindstrong, Vironix Health, Pulmocide. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

PneumoWave and ZOLL-Itamar Remote Patient Monitoring Business Unit (Formerly Spry Health) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

PneumoWave

General Information

Discover More

About PneumoWave

Services & Products

Target Customers

Funding Rounds & Investors (2)

PneumoWave Alternatives & Competitors

FAQ About PneumoWave